Medscape Hematology-Oncology Headlines 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.How Do Patients View Their Cancer Test Results? How Do Patients View Their Cancer Test Results?
With electronic patient portals, patients see their test results sooner and more frequently before their clinician, a recent analysis found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
No Added Benefit From Chemo in This Breast Cancer Subtype No Added Benefit From Chemo in This Breast Cancer Subtype
Adding chemotherapy to endocrine therapy for women with ER-positive, HER2-negative invasive lobular carcinoma does not improve survival outcomes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Phase 1 Trials: Are We Using Optimal Drug Dose Schedules? Phase 1 Trials: Are We Using Optimal Drug Dose Schedules?
David J. Kerr, CBE, MD, DSc, discusses considerations for dosing schedules in Phase 1 trials.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
New Trials in Breast Cancer: Could Your Patient Benefit? New Trials in Breast Cancer: Could Your Patient Benefit?
Patients with breast cancer might be eligible to enroll in one of these clinical trials.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 27, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Is It Possible to Predict the Risk for Pancreatic Cancer? Is It Possible to Predict the Risk for Pancreatic Cancer?
A US-based team seeks to develop and validate a model allowing clinicians to predict the risk for pancreatic cancer.MDedge (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 21, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
AI in Oncology: Sorting Through Misinformation AI in Oncology: Sorting Through Misinformation
David J. Kerr, CBE, MD, DSc, discusses the use of artificial intelligence in oncology now and in the future.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 21, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
The Latest Findings on Major Breast Cancer Trials The Latest Findings on Major Breast Cancer Trials
Here ' s a roundup of the most recent data from five phase 3 trials presented at SABCS 2023.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 21, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Serum Hormones May Predict AI Benefit for BC Prevention Serum Hormones May Predict AI Benefit for BC Prevention
Measuring serum hormone concentrations in postmenopausal women at high risk for developing BC may help identify those most likely to benefit from preventive treatment with an aromatase inhibitor.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 21, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
ESD Curbs Adenoma Recurrence but More Adverse Events ESD Curbs Adenoma Recurrence but More Adverse Events
For large colonic adenomas, endoscopic submucosal dissection reduces the recurrence rate compared with endoscopic mucosal resection, but the adverse event rate is higher.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 20, 2023 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news
New Multiple Myeloma Staging Systems Outperform the Standard New Multiple Myeloma Staging Systems Outperform the Standard
Findings from a large US cohort study show comparable accuracy, but better discrimination of patients across disease stages.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 20, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
GLP-1 RAs Associated With Reduced CRC Risk in T2DM GLP-1 RAs Associated With Reduced CRC Risk in T2DM
The effects were more profound in patients with overweight and obesity in addition to diabetes.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 19, 2023 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news
FDA OKs Enfortumab Vedotin Plus Pembro for Urothelial Cancer FDA OKs Enfortumab Vedotin Plus Pembro for Urothelial Cancer
The combination is the first approved alternative to first-line chemotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 18, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
EU Conditional Approval: Gene Editor to Treat Blood Diseases EU Conditional Approval: Gene Editor to Treat Blood Diseases
The single-dose therapy involves treating and editing patient stem cells ex vivo, then reinfusing them.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 18, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Checkpoint Therapeutics Slides After US FDA Declines Cancer Therapy Approval Checkpoint Therapeutics Slides After US FDA Declines Cancer Therapy Approval
Checkpoint Therapeutics said on Monday the U.S. Food and Drug Administration had declined to approve its experimental therapy to treat a form of skin cancer following an...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 18, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Belzutifan Approved for Advanced Renal Cell Carcinoma Belzutifan Approved for Advanced Renal Cell Carcinoma
The FDA approval makes belzutifan the first agent specifically indicated for renal cell carcinoma that has progressed after checkpoint inhibition and a VEGF-TKI.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 15, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
